GIBRALTAR INDUSTRIES, INC. financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data GIBRALTAR INDUSTRIES, INC. files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	1,008	987	837	898	1,033	1,340	1,390	1,047	1,023	1,136
Cost of revenue	763	750	626	678	776	1,050	1,071	765	722	830
Gross profit	245	237	211	220	256	290	319	282	301	305
Research and development	2.2	2.9	1.7
Selling, general and administrative	161	143	128	139	149	185	189	158	156	182
Operating income	73.5	92.8	81.1	80.8	107	97	130	121	140	123
Interest expense	14.6	14	12.1
Interest income	0.14	0.57	2.16	0.76	0.28	0.27	0.17	0.68
Other non-operating income								5.03	25.1	2.08
Pre-tax income	50	77.9	67.1	78.1	108	99.6	111	124	171	127
Income tax	16.3	14.9	13	18.2	24.5	25	29.1	32.2	35.9	29
Income from continuing operations	33.7	63	54.1	59.9	83.3	74.5	82.4	91.4	135	97.6
Net income	33.7	62.6	63.8	65.1	64.6	75.6	82.4	111	137	-44.4
EBITDA	97.6	115	98.6	98.4	128	129	156	139	159	153
EPS, basic	1.07	1.97	2.00	2.01	1.98	2.30	2.57	3.61	4.50	-1.48
EPS, diluted	1.05	1.94	1.96	1.99	1.96	2.29	2.56	3.59	4.46	-1.48
Shares, basic (weighted)	31.5	31.7	32	32.4	32.7	32.9	32.1	30.6	30.5	29.9
Shares, diluted (weighted)	32.1	32.3	32.5	32.7	32.9	33.1	32.2	30.8	30.8	30

Balance sheet

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Cash and equivalents	170	222	297	191	32.1	12.8	17.6	99.4	269	116
Receivables	124	145	140	134	198	236	217	173	115	120
Inventory	89.6	86.4	98.9	62	98.3	176	170	121	93.3	117
Other current assets	7.34	8.73	8.35	19	19.7	21.5	18.8	17.8	22.3	56.9
Total current assets	391	463	545	437	425	447	424	462	651	629
Property, plant and equipment	108	97.1	95.8	78.2	89.6	96.9	110	108	87.1	130
Lease right-of-use assets				21.2	25.2	18.1	26.5	44.9	41.6	55.4
Goodwill	304	321	302	307	514	511	512	329	323	415
Intangible assets	111	106	96.4	76.7	156	142	138	126	26.1	34.5
Other non-current assets	3.92	4.68	1.22	1.98	1.6	0.48	0.7	2.32	1.94	20.3
Total assets	918	991	1,062	984	1,212	1,215	1,211	1,256	1,419	1,394
Accounts payable	69.9	82.4	79.1	72.6	135	172	107	92.1	90.7	108
Accrued liabilities	70.4	75.5	87.1	86.6	83.5	68	73.7	88.7	65.9	156
Deferred revenue		12.8	17.9	47.6	34.7	46.7	35	44.7	14.8	8.88
Short-term debt	0.4	0.4	209	0
Total current liabilities	152	171	393	229	302	287	215	226	255	366
Long-term debt	209	210	1.6	0	85.6	23.8	88.8	0		0
Lease liabilities				14.9	17.7	11.4	19	36	33.4	46.2
Other non-current liabilities	58	47.8	34	21.3	24	27.2	18.3	22.8	24.7	25.9
Total liabilities	457	460	465	310	469	390	389	341	371	443
Total debt	210	210	210	0	85.6	23.8	88.8	0	0	0
Paid-in capital	264	272	283	296	305	315	323	333	344	353
Retained earnings	212	275	339	406	470	546	628	739	876	831
Treasury stock	-7.89	-10.8	-17.9	-22.2	-28.9	-35.4	-126	-154	-166	-231
Other comprehensive income	-7.72	-4.37	-7.23	-5.39	-2.46	0.19	-3.43	-2.11	-5.33	-3.68
Shareholders' equity	461	532	597	674	744	825	822	915	1,048	950
Total equity	461	532	597	674	744	825	822	915	1,048	950
Total liabilities and equity	918	991	1,062	984	1,212	1,215	1,211	1,256	1,419	1,394
Shares outstanding	32.1	32.3	32.9		33.6	33.8	34.1	34.2	34.3	34.5

Cash flow statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Net income	33.7	62.6	63.8	65.1	64.6	75.6	82.4	111	137	-44.4
Depreciation and amortization	24.1	21.7	17.4	17.6	20.9	32	26.2	18.7	19.1	29.8
Stock-based compensation	6.37	7.12	9.19	12.6	8.17	8.65	8.33	8.87	10	8.34
Deferred income tax	-4.89	-7.11	4.73	4.12	3.79	2.97	6.34	11.6	-0.28	-1.97
Change in receivables	37.8	-21.8	9.67	-11.3	2.28	-41.9	32.8	0.4	-2.73	12.2
Change in inventory	11.8	0.87	-12.3	14.3	-5.72	-85.8	14.4	41.4	1.83	-4.93
Change in payables	-17.1	11.3	-5.49	4.8	-1.16	38.4	-76.3	-16.4	28.4	7.2
Cash from operations	124	70.1	97.5	130	89.1	23.1	103	218	174	167
Capital expenditures	-10.8	-11.4	-10.4	-8.78	-13.1	-17.7	-20.1	-13.9	-17.4	-46.4
Acquisitions	-23.4	-18.5	-5.24	-8.6	-314	4.14	-51.6	-9.86	0	-211
Cash from investing	-23.9	-16.8	-14.5	-19.7	-327	24.5	-71.7	-15.7	8.54	-257
Debt issued	0	0	0	0	85	59.5	205	50	0	0
Debt repaid	-0.4	-0.4	-0.4	-212	0	-121	-138	-141	0	0
Stock issued	3.34	0.67	1.39	0.49	1.12	1.02	0	0	0	0.2
Share buybacks	-1.54	-2.87	-7.17	-4.31	-6.66	-6.5	-89.5	-29.3	-12.2	-63.9
Cash from financing	1.35	-2.6	-6.18	-217	79.5	-66.6	-25	-120	-12.2	-63.7
Exchange rate effect	-0.15	1.43	-2.09	1.15	-1.17	-0.2	-1.24	-0.61	-0.57	0.32
Net change in cash	101	52.1	74.7	-106	-159	-19.2	4.76	81.8	170	-154
Free cash flow	113	58.7	87.2	121	76	5.37	82.6	205	157	121
Interest paid	14	14	12.3	2.71	0.63	1.56	3.54	3.55	1.05	1.21
Income taxes paid	-17.7	26.2	14.1	16.7	21.4	22.1	27	23.4	31	0.23

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $40.56 on September 25, 2026.

Profitability

Metric	Value	How it is calculated
Gross margin	24.8%	Gross profit / revenue.
Operating margin	7.6%	Operating income / revenue.
EBITDA margin	11.0%	EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin	5.4%	Pre-tax income / revenue.
Net margin	-10.4%	Net income / revenue.
FCF margin	2.9%	Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin	4.9%	Cash from operations / revenue.
Effective tax rate	23.1%	Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)	-16.9%	Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)	-5.4%	Net income / average total assets.
Return on invested capital (ROIC)	4.0%	Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
SG&A / revenue	17.2%	Selling, general and administrative expense / revenue.
Stock-based pay / revenue	0.5%	Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue	2.0%	Capital expenditures / revenue.
D&A / revenue	3.4%	Depreciation and amortization / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	11.0%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	-6.5%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y	1.9%	Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y	1.3%	Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y	-1.4%	Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y	3.5%	Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y	-12.1%	Operating income vs the same period a year earlier. Only from a positive base.
Operating income CAGR, 3y	-1.9%	Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating income CAGR, 5y	2.7%	Compound annual growth of operating income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EBITDA growth, 1y	-3.9%	EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y	-0.8%	Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA CAGR, 5y	3.6%	Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Net income growth, 1y	-132.3%	Net income vs the same period a year earlier. Only from a positive base.
EPS growth, 1y	-133.2%	EPS vs the same period a year earlier. Only from a positive base.
Operating cash flow growth, 1y	-4.2%	Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y	17.6%	Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y	13.4%	Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow growth, 1y	-23.1%	Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 3y	13.5%	Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Free cash flow CAGR, 5y	9.7%	Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y	-9.3%	Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y	5.0%	Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y	5.0%	Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y	-1.8%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	4.8%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	2.8%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y	-2.6%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	-2.3%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y	-1.8%	Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	1.46x	Current assets / current liabilities.
Quick ratio	0.56x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	0.03x	(Cash + short-term investments) / current liabilities.
Debt / equity	1.37x	Total debt / shareholders' equity. Not shown when equity is negative.
Debt / assets	43.7%	Total debt / total assets.
Liabilities / assets	68.0%	Total liabilities / total assets.
Net debt	$1.20B	Total debt - cash - short-term investments. Negative means more cash than debt.
Net debt / EBITDA	7.55x	Net debt / EBITDA (twelve months), when EBITDA is positive.
Working capital	$223.5M	Current assets - current liabilities.
Goodwill and intangibles / assets	33.7%	(Goodwill + intangible assets) / total assets.
Tangible book value	-$48.3M	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	0.52x	Revenue / average total assets.
Fixed asset turnover	7.59x	Revenue / average property, plant and equipment.
Inventory turnover	4.06x	Cost of revenue / average inventory.
Days inventory	90 days	365 x average inventory / cost of revenue.
Receivables turnover	5.56x	Revenue / average receivables.
Days sales outstanding	66 days	365 x average receivables / revenue.
Days payables	71 days	365 x average accounts payable / cost of revenue.
Cash conversion cycle	85 days	Days inventory + days sales outstanding - days payables.
Capex / operating cash flow	40.3%	Capital expenditures / cash from operations, when that is positive.

Per share

Metric	Value	How it is calculated
EPS, diluted	-$5.06	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share	$48.49	Revenue / diluted weighted shares.
FCF per share	$1.42	Free cash flow / diluted weighted shares.
Operating cash flow per share	$2.38	Cash from operations / diluted weighted shares.
Book value per share	$25.83	Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share	-$1.40	Tangible book value / shares outstanding.
Cash per share	$0.44	(Cash + short-term investments) / shares outstanding.
Buybacks / FCF	12.5%	Share buybacks / free cash flow, when free cash flow is positive.

Valuation

Metric	Value	How it is calculated
Market cap	$1.20B	Share price x shares outstanding.
Enterprise value	$2.41B	Market cap + total debt - cash - short-term investments.
P/S	0.83x	Market cap / revenue.
P/B	1.35x	Market cap / shareholders' equity. Only when equity is positive.
P/FCF	28.4x	Market cap / free cash flow. Only when free cash flow is positive.
P/OCF	16.9x	Market cap / cash from operations, when positive.
EV/Sales	1.67x	Enterprise value / revenue.
EV/EBIT	21.9x	Enterprise value / operating income, when both are positive.
EV/EBITDA	15.1x	Enterprise value / EBITDA, when both are positive.
EV/FCF	56.8x	Enterprise value / free cash flow, when both are positive.
FCF yield	3.5%	Free cash flow / market cap.
Earnings yield	-12.5%	Net income / market cap (the inverse of P/E).
Shareholder yield	0.4%	(Dividends paid + share buybacks) / market cap.

What was GIBRALTAR INDUSTRIES, INC.'s revenue in fiscal 2025?

GIBRALTAR INDUSTRIES, INC. reported revenue of $1.14B for fiscal 2025, 11% higher than the year before.

Was GIBRALTAR INDUSTRIES, INC. profitable in fiscal 2025?

No. It reported a net loss of $44.4M.

How much free cash flow did GIBRALTAR INDUSTRIES, INC. generate in fiscal 2025?

Cash from operations of $167.0M minus capital expenditures of $46.4M left free cash flow of $120.6M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to GIBRALTAR INDUSTRIES, INC.